A 46 plaintiff Cymbalta lawsuit has been filed against Eli Lilly and Company, alleging that they suffered severe antidepressant discontinuation syndrome symptoms when they attempted to wean themselves off Cymbalta.

Cymbalta Withdrawal Lawsuit Claims

The 46 plaintiffs are residents from numerous states across the United States but all jointly allege that they suffered personal injuries and damages from their use of Cymbalta and their subsequent development of Cymbalta withdrawal symptoms.

According to their Cymbalta withdrawal lawsuit, Eli Lilly under-reported the prevalence of withdrawal symptoms, which according to Lilly’s own research occurs in at least 44 percent of patients instead of the one to two percent cited on Cymbalta’s label.

The plaintiffs allege that their Cymbalta withdrawal injuries are “a result of Lilly’s failure to provide both: (a) adequate instructions for discontinuing use of Cymbalta, and (b) an adequate warning that fully and accurately informed Plaintiffs about the frequency, severity, and duration of symptoms associated with Cymbalta withdrawal.”

Since its FDA approval in 2004, Eli Lilly has aggressively marketed their antidepressant drugs to the public and medical community. However, “Lilly’s promotional campaigns have continuously failed to provide adequate instructions to users and health care professionals for discontinuing Cymbalta,” according to the Cymbalta withdrawal lawsuit.

The plaintiffs further allege that the drug manufacturer did not properly inform users or prescribing doctors of “the frequency, severity, and duration of Cymbalta withdrawal.”

Some of the Cymbalta Withdrawal symptoms experienced by the plaintiffs in this Cymbalta withdrawal lawsuit include:

• Headaches
• Dizziness
• Nausea
• Fatigue
• Diarrhea
• Paresthesia
• Vomiting
• Irritability
• Nightmares
• Insomnia
• Anxiety
• Hyperhidrosis
• Sensory disturbances
• Electric shock sensations
• Seizures
• Vertigo

Cymbalta withdrawal symptoms can occur even when a patient is not intentionally attempting to decrease their dosage or stop the medication completely. It can even occur when a patient forgets to take their daily dose of the antidepressant drug.

Additionally, the fact that the smallest dose of Cymbalta a patient can be prescribed is 20 milligrams means that there is not effective way to slowly decrease the antidepressant dosage to zero without essentially quitting cold turkey. This may be a contributing factor to the large percentage of users that experience Cymbalta withdrawal symptoms.

Plaintiffs Seek Relief In Cymbalta Lawsuit

The 46 plaintiffs of this Cymbalta antidepressant discontinuation syndrome lawsuit jointly lodge several allegations against Eli Lilly, including claims of negligence, design defect, failure to warn, negligent misrepresentation, fraud, and breach of implied warranty.

They are seeking compensation for economic and non-economic damages that include “past and future medical expenses, medical monitoring, out-of-pocket expenses, past and future physical pain and mental anguish, past and future physical impairment, past and future loss of companionship and consortium, and past and future loss of household services.”

This Cymbalta withdrawal lawsuit also seek Eli Lilly to pay general damages, future damages resulting from permanent injuries, compensation for psychological trauma, pain and suffering, loss of enjoyment of life, punitive damages, and payment of plaintiffs’ attorney’s fees.

The Cymbalta Withdrawal Lawsuit is Case No. 1:15-cv-00922-JMS-MJD, in the U.S. District Court for the Southern District of Indiana.